seri
natur
occur
cardenolid
exhibit
potent
antitransmiss
gastroenter
viru
tgev
activ
swine
testicular
st
cell
identifi
immunofluoresc
assay
cardenolid
found
diminish
express
tgev
nucleocapsid
spike
protein
use
indic
viral
replic
block
tgev
infect
induc
apoptosi
cytopath
effect
impart
trend
inhibitori
activ
na
k
atpas
antitgev
activ
viral
titer
inhibit
found
take
place
dosedepend
manner
knock
express
na
k
atpas
cellular
receptor
cardenolid
st
cell
found
significantli
impair
suscept
st
cell
tgev
infect
thu
identifi
na
k
atpas
antivir
drug
target
antagonist
cardenolid
novel
class
antitgev
agent
cardenolid
also
known
cardiac
glycosid
c
steroid
bind
act
alloster
inhibitor
na
k
atpas
membranebound
protein
establish
maintain
high
intern
k
low
intern
na
cellular
concentr
anim
cell
agraw
et
al
na
k
atpas
compos
two
subunit
auxiliari
subunit
bind
atp
na
k
ion
well
alloster
bind
cardenolid
combin
subunit
subunit
shown
exhibit
differ
kinet
paramet
includ
select
cardenolid
tissu
distribut
baker
bechmann
et
al
habeck
et
al
katz
et
al
although
natur
occur
cardenolid
often
toxic
medic
use
exampl
small
dose
ouabain
digoxin
digitoxin
use
treat
hypotens
cardiac
arrhythmia
heart
failur
prassa
diamandi
moreov
use
cardioton
steroid
like
ouabain
digitoxin
oleandrin
report
potenti
mean
combat
human
cancer
diederich
et
al
platz
et
al
reduc
viral
product
murin
leukemia
viru
hemagglutin
viru
japan
herp
simplex
viru
type
cultur
cell
nagai
et
al
su
et
al
tomita
kuwata
exact
natur
scope
therapeut
effect
cardenolid
howev
remain
unravel
coronavirus
cov
glycoproteinenvelop
virus
positivesens
singlestrand
rna
genom
eg
human
middl
east
respiratori
syndrom
mer
cov
sever
acut
respiratori
syndrom
sar
cov
human
transmiss
gastroenter
coronaviru
tgev
murin
hepat
viru
mhv
group
common
ancient
divers
virus
caus
respiratori
gastrointestin
central
nervou
system
diseas
recogn
varieti
host
receptor
infect
mani
host
health
threat
human
anim
epidemiolog
cov
viral
strain
determin
cognat
cell
receptor
chan
et
al
weiss
navasmartin
tgev
belong
famili
coronavirida
caus
transmiss
gastroenter
highli
contagi
diseas
caus
devast
econom
loss
tgev
infect
age
categori
pig
mortal
rate
close
young
pig
tgev
spike
protein
bind
porcin
aminopeptidas
n
cell
membran
receptor
aid
entri
cell
weiss
navasmartin
mani
small
chemic
molecul
exert
anticoronaviru
activ
via
target
either
viral
entri
intracellular
viral
life
cycl
tong
tong
addit
small
protein
griffithsin
directli
target
interact
coronavir
spike
glycoprotein
interfer
cell
entri
therebi
exhibit
effici
inhibit
viral
infect
broad
spectrum
cov
includ
tgev
sar
cov
mer
cov
millet
et
al
okeef
et
al
howev
report
toxicolog
appli
pharmacolog
toxicolog
appli
pharmacolog
j
u
r
n
l
h
e
p
g
e
w
w
w
e
l
e
v
e
r
c
l
c
e
p
coronaviru
inhibit
via
target
membran
protein
nonvir
receptor
herein
identifi
membran
protein
na
k
atpas
antivir
novel
target
antagonist
cardenolid
antivir
tgev
cell
virus
immunofluoresc
assay
ifa
cytopath
effect
cytotox
assay
swine
testicular
st
epitheli
cell
taiwan
field
isol
virul
strain
tgev
grown
propag
ifa
cytopath
effect
cytotox
assay
regard
tgev
also
describ
yang
et
al
yang
et
al
two
modif
test
compound
pretreat
h
st
cell
infect
tgev
multipl
infect
moi
ifa
cytopath
effect
moi
determin
viru
titer
murin
astrocytoma
cell
line
dbt
mhv
jhm
strain
maintain
describ
ifa
cytopath
effect
regard
mhv
moi
also
perform
describ
lee
et
al
adenosin
atpas
porcin
cerebr
cortex
sigma
co
reconstitut
mm
trishcl
ph
per
manufactur
instruct
enzym
hydrolyz
atp
adp
orthophosph
hydrolysi
coupl
exchang
sodium
potassium
ion
across
plasma
membran
sigma
co
na
k
atpas
activ
assay
reaction
mixtur
contain
u
atpas
mm
nacl
mm
kcl
mm
trishcl
ph
mm
egta
mm
sigma
co
test
compound
vehicl
indic
briefli
reaction
mixtur
incub
test
compound
dmso
min
sigma
co
ad
initi
enzymat
reaction
min
reaction
quench
addit
trichloroacet
acid
subject
centrifug
min
result
supernat
dilut
h
measur
pi
gener
enzymat
reaction
use
molybdenum
blue
method
p
reagent
innova
bioscienc
colorimetr
develop
read
nm
use
beckman
coulter
detect
platform
assay
perform
describ
yang
et
al
use
antibodi
gapdh
cell
signal
technolog
inc
usa
na
k
atpas
abcam
inc
cambridg
uk
tylophorin
reevesiosid
ai
prepar
describ
chang
et
al
yang
et
al
dmso
digoxin
hplc
digitoxin
hplc
digitoxigenin
tlc
ouabain
hplc
dihydroouabain
tlc
oleandrin
hplc
monophosph
sodium
salt
db
camp
hplc
aldosteron
hplc
purchas
sigmaaldrich
st
loui
mo
usa
st
cell
plate
densiti
cell
per
well
wellplat
contain
ml
mem
cultur
medium
contain
fb
follow
incub
overnight
test
compound
ad
well
h
prior
addit
tgev
moi
plate
incub
addit
h
indic
quantifi
viral
yield
cell
supernat
cell
specif
treatment
harvest
subject
viral
titer
determin
via
endpoint
dilut
assay
conduct
st
cell
mean
valu
sd
calcul
three
independ
experi
serial
dilut
supernat
prepar
inocul
cultur
cell
plastic
plate
contain
eight
sampl
seri
dilut
number
cell
cultur
infect
determin
viru
dilut
look
cytopath
effect
endpoint
viral
dilut
lead
cytopath
effect
inocul
well
estim
use
reed
muench
method
design
one
tissu
cultur
infect
dose
use
measur
infecti
tgev
viru
titer
approxim
tcid
pfu
plaqueform
unit
pseudotyp
lentiviru
contain
na
k
atpas
shrna
clone
id
neg
controlshrna
shlacz
clone
id
academia
sinica
taiwan
transduc
st
cell
moi
cultur
medium
contain
polybren
millipor
h
post
transduct
cell
cultur
presenc
puromycin
select
select
cell
show
knockdown
express
na
k
atpas
valid
western
blot
analysi
prior
tgev
infect
follow
experi
cdna
mhv
n
protein
amplifi
pcr
specif
primer
pair
tag
bamhi
ecori
restrict
enzym
site
respect
result
pcr
fragment
digest
bamhi
ecori
subclon
express
vector
gener
express
plasmid
construct
transform
escherichia
coli
strain
induc
express
glutathion
stransferas
gst
fuse
n
protein
mm
iptg
subsequ
protein
express
purif
cleavag
n
protein
yang
et
al
shown
repres
independ
experi
surviv
rate
compound
treatment
compar
vehicl
treatment
tgev
infect
st
cell
respect
student
ttest
use
analyz
signific
p
valu
gstmhv
n
fuse
protein
carri
describ
yang
et
al
purifi
mhv
n
protein
use
antigen
gener
monoclon
antibodi
work
perform
ltk
laboratori
taiwan
carri
accord
manufactur
protocol
briefli
five
mice
immun
emulsifi
mg
antigen
mhv
n
protein
complet
adjuv
three
week
five
booster
inject
given
everi
two
week
antigen
incomplet
adjuv
fifth
inject
mous
blood
collect
titer
test
mous
abl
produc
antibodi
n
protein
mous
spleen
cell
fuse
myeloma
cell
gener
immort
hybridoma
cell
produc
antibodi
antibodi
gener
hybridoma
cell
dilut
obtain
monoclon
hybridoma
cell
gener
monoclon
antibodi
obtain
monoclon
hybridoma
cell
line
abl
gener
antibodi
react
antigen
mhv
n
protein
individu
inject
respect
mous
periton
caviti
result
ascit
fluid
contain
monoclon
antibodi
mhv
n
protein
collect
use
experi
describ
cellbas
system
compris
tgev
infect
st
cell
ifa
yang
et
al
use
screen
laboratori
collect
natur
product
nativ
plant
taiwan
antitgev
agent
st
cell
pretreat
test
compound
h
prior
infect
tgev
moi
h
tgev
infect
st
cell
fix
subject
ifa
antibodi
specif
n
protein
tgev
reevesiosid
reevesiosid
f
epireevesiosid
f
possess
structur
featur
similar
found
cardenolid
found
impart
potent
antitgev
activ
ic
valu
nm
nm
nm
respect
accordingli
cardenolid
sought
antitgev
activ
could
test
digoxin
digitoxin
oleandrin
ouabain
amongst
other
also
found
impart
potent
antitgev
activ
ic
valu
nm
respect
tabl
next
examin
inhibitori
activ
cardenolid
na
k
atpas
found
correl
trend
inhibit
tgev
na
k
atpas
tabl
repres
structur
dose
depend
inhibit
curv
ic
valu
ifa
result
compound
shown
fig
b
c
respect
moreov
n
protein
express
western
analys
tgev
infect
st
cell
also
exhibit
dose
depend
manner
decreas
treatment
oleandrin
reevesiosid
fig
na
k
atpas
protein
level
significantli
affect
upon
tgev
infect
st
cell
fig
thu
cardenolid
na
k
atpas
inhibitor
protect
st
cell
tgev
replic
tgev
infect
st
cell
show
signific
level
activ
h
post
infect
hpi
reveal
cleavag
activ
polypeptid
yang
et
al
moreov
tgev
infect
st
cell
subsequ
show
cytopath
effect
round
enlarg
cell
format
syncytia
detach
cell
medium
yang
et
al
concentr
ouabain
oleandrin
digitoxin
reevesiosid
reevesiosid
f
epireevesiosid
f
exert
strong
protect
activ
less
potent
dehydroouabain
reevesiosid
gepireevesiosid
g
fig
shown
fig
tylophorin
posit
control
display
protect
tgevinfect
cytotox
expect
cardenolid
show
protect
effect
cytopath
effect
similar
activ
accordingli
less
potent
dihydroouabain
reevesiosid
gepireevesiosid
g
higher
concentr
exhibit
better
protect
effect
activ
fig
cytopath
effect
fig
similar
result
conclus
also
obtain
cell
viabil
measur
mt
fig
cardenolid
reevesiosid
oleandrin
test
abil
elimin
tgev
titer
infect
st
cell
tgev
exhibit
log
phase
increas
viral
yield
reach
plateau
hpi
titer
pfuml
data
shown
publish
elsewher
treatment
reevesiosid
oleandrin
significantli
block
viral
replic
diminish
viral
yield
result
reduct
viral
yield
magnitud
order
concentr
nm
nm
fig
n
protein
express
fig
tgev
infect
st
cell
dose
depend
manner
hpi
result
consist
describ
antitgev
activ
cardenolid
fig
tabl
base
find
role
na
k
atpas
antitgev
cardenolid
next
examin
knock
na
k
atpas
express
st
cell
rna
silenc
approach
two
distinct
clone
id
see
materi
method
obtain
stabl
express
clone
test
respons
tgev
infect
fig
na
k
atpas
express
knock
respect
result
tgev
infect
cell
express
rel
less
tgev
n
protein
fig
effect
cardenolid
reduc
tgev
yield
dose
depend
effect
reevesiosid
oleandrin
reduc
tgev
yield
b
dose
depend
effect
reevesiosid
oleandrin
reduc
tgev
n
protein
express
st
cell
seed
day
compound
treatment
tgev
infect
test
compound
ad
well
h
prior
addit
tgev
moi
result
cultur
incub
addit
h
indic
supernat
cell
specif
treatment
collect
subject
viral
titer
determin
via
endpoint
dilut
assay
conduct
tgev
infect
st
cell
wherea
adher
cell
harvest
western
analysi
result
shown
averag
sd
repres
result
three
independ
experi
fig
deplet
na
k
atpas
express
decreas
suscept
st
cell
tgev
infect
na
k
atpas
knockdown
st
cell
harbor
express
significantli
less
tgev
n
protein
infect
tgev
compar
st
cell
harbor
controlshrna
rel
express
level
na
k
atpas
tgev
n
protein
averag
sd
three
experi
shown
respect
western
blot
b
ifa
antibodi
n
protein
tgev
moi
infect
st
cell
hpi
control
na
k
atpas
shrna
c
quantiz
immunofluoresc
shown
b
effect
na
k
atpas
activ
aldosteron
db
camp
na
k
atpas
tgev
activ
st
cell
result
shown
averag
sd
repres
result
three
independ
experi
ic
valu
combin
treatment
compar
cardenolid
treatment
alon
tgev
infect
st
cell
respect
student
ttest
use
analyz
signific
p
valu
fig
measur
rel
tgev
n
express
level
ifa
tgev
infect
cell
harbor
controlshrna
use
indic
tgev
infect
fig
na
k
atpas
deplet
cell
clone
retain
infect
tgev
respect
compar
controlshrna
cell
correl
rel
na
k
atpas
express
level
correspond
infect
fig
moreov
aldosteron
db
camp
report
increas
na
k
atpas
level
activ
delamer
king
ferail
et
al
gonin
et
al
salyer
et
al
therefor
appli
perform
gainoffunct
experi
na
k
atpas
tgev
infect
found
aldosteron
db
camp
moder
augment
na
k
atpas
protein
level
st
cell
fig
increas
infect
tgev
fig
furthermor
aldosteron
db
camp
abl
antagon
antitgev
activ
cardenolid
fig
therefor
conclud
na
k
atpas
contribut
tgev
infect
st
cell
combin
na
k
atpas
isoform
determin
select
na
k
atpas
inhibit
cardenolid
baker
bechmann
et
al
habeck
et
al
katz
et
al
host
cell
receptor
differ
coronavir
specif
recognit
infect
millet
et
al
weiss
navasmartin
test
whether
cardenolid
exert
antimhv
activ
even
higher
test
concentr
tgev
cardenolid
exhibit
signific
protect
mhv
infect
dbt
cell
cytopath
effect
fig
induc
mhv
significantli
diminish
mhv
antigen
n
protein
express
analyz
ifa
fig
western
analysi
fig
natur
occur
cardenolid
ouabain
digoxin
digitoxin
often
toxic
nevertheless
therapeut
cardiac
diseas
herein
explor
antivir
activ
cardenolid
identifi
novel
class
antitgev
agent
expos
na
k
atpas
potenti
drug
target
futur
antivir
medic
differ
coronavirus
recogn
specif
host
cell
receptor
infect
blau
et
al
chan
et
al
weiss
navasmartin
murin
coronaviru
mhv
coronaviru
caus
epidem
murin
ill
high
mortal
infect
murin
cell
carcinoembryon
antigenrel
cell
adhes
cell
surfac
receptor
receptor
attach
entri
blau
et
al
weiss
navasmartin
tgev
use
bind
membran
aminopeptidas
n
cell
receptor
viral
entri
weiss
navasmartin
identifi
antitgev
cardenolid
exert
antimhv
activ
term
reduct
mhv
induc
cytopath
effect
viral
protein
express
fig
moreov
cardenolid
inhibit
na
k
atpas
select
combin
isoform
baker
bechmann
et
al
habeck
et
al
katz
et
al
cell
express
differ
rel
level
subunit
also
determin
respons
cardenolid
yang
et
al
thu
combin
na
k
atpas
isoform
specif
cell
receptor
coronaviru
suggest
import
select
cardenolid
tgev
mhv
moreov
also
merit
explor
antivir
activ
cardenolid
coronavirus
addit
mention
whether
na
k
atpas
coupl
cellular
signal
pathway
newman
et
al
upon
bind
cardenolid
contribut
antitgev
activ
also
investig
laboratori
furthermor
aminopeptidas
n
na
k
atpas
membran
protein
report
locat
membran
raft
dalskov
et
al
navarret
santo
et
al
welker
et
al
aminopeptidas
n
also
known
regul
na
k
atpas
activ
kotlo
et
al
thu
mutual
interact
also
possibl
inhibitori
activ
cardenolid
tgev
take
place
partli
coupl
interact
aminopeptidas
n
na
k
atpas
find
merit
investig
transpar
document
associ
articl
found
onlin
version
